• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

Introduction to 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide (CAS No. 954250-47-6)

2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide, identified by the CAS number 954250-47-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of amides, characterized by its molecular structure, which includes a chloro-substituted benzene ring linked to an acetamide moiety. The presence of a piperidine ring further enhances its pharmacological relevance, making it a valuable scaffold for drug discovery and development.

The chemical formula of 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide can be represented as C??H??ClN?O, reflecting its composition of carbon, hydrogen, chlorine, nitrogen, and oxygen atoms. The molecular weight of this compound is approximately 218.71 g/mol, which is within the range commonly observed for pharmacologically active molecules. Its solubility profile in various solvents suggests potential applications in formulation development, with moderate solubility in polar organic solvents such as methanol and ethanol.

In recent years, the pharmaceutical industry has increasingly focused on developing novel compounds that exhibit enhanced efficacy and reduced side effects. 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide has emerged as a promising candidate in this regard, primarily due to its structural features that allow for selective interactions with biological targets. The chloro-substituent on the benzene ring and the piperidine moiety contribute to its binding affinity with enzymes and receptors involved in various metabolic pathways.

One of the most compelling aspects of 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide is its potential role as an intermediate in the synthesis of more complex pharmaceutical agents. Researchers have leveraged its structural framework to develop derivatives with improved pharmacokinetic properties. For instance, modifications at the N-methyl group or the piperidine ring have been explored to enhance bioavailability and target specificity. These modifications align with current trends in drug design, where structural optimization is key to achieving therapeutic efficacy.

The synthesis of 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide involves multi-step organic reactions, typically starting from commercially available precursors such as 4-chlorobenzoyl chloride and N-methylpiperidine derivatives. The process often includes condensation reactions followed by purification steps to isolate the desired product in high yield and purity. Advances in synthetic methodologies have enabled more efficient production routes, reducing costs and improving scalability for industrial applications.

Recent studies have highlighted the pharmacological potential of 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide in addressing various therapeutic challenges. For example, preliminary investigations suggest that this compound may exhibit inhibitory effects on certain enzymes implicated in inflammatory responses and cancer progression. The piperidine ring, a common pharmacophore in many bioactive molecules, plays a crucial role in modulating these interactions. Additionally, the chloro-substituent enhances lipophilicity, facilitating cellular uptake and target engagement.

The compound's mechanism of action remains an area of active research. However, early studies indicate that it may interact with transcription factors and signaling pathways involved in cell proliferation and differentiation. These interactions could make it a valuable tool for developing treatments against chronic diseases such as cancer and neurodegenerative disorders. Furthermore, its ability to cross the blood-brain barrier suggests potential applications in central nervous system (CNS) drug development.

In terms of safety profile, 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide has been evaluated through in vitro assays to assess its toxicity and immunogenicity. Preliminary findings suggest that it exhibits low toxicity at therapeutic concentrations but may require further testing to rule out any long-term adverse effects. As with any pharmacological agent, comprehensive toxicological studies are essential before considering clinical translation.

The future prospects of 2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide are promising, given its versatile structural features and potential therapeutic applications. Ongoing research aims to refine its synthetic pathways for cost-effective production while exploring new derivatives with enhanced properties. Collaborative efforts between academic institutions and pharmaceutical companies are likely to accelerate progress in this field.

In conclusion,2-Chloro-N-methyl-N-(1-methylpiperidin-4-yl)acetamide (CAS No. 954250-47-6) represents a significant advancement in medicinal chemistry with broad implications for drug discovery and development. Its unique structural attributes make it a valuable scaffold for designing novel therapeutics targeting various diseases. As research continues to uncover its full potential,this compound is poised to play a pivotal role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)